Skip to main content

Global Orthopedic Implants Market to Expand at 4% CAGR With Minimally Invasive Surgery Demand 2030

 


The global orthopedic implants market is expected to grow at a CAGR of ~4% during the forecast period. Increasing geriatric population, rising incidence of chronic conditions such as osteoarthritis and osteoporosis, growing number of road accidents and sports injuries, advancements in biomaterials and 3D printing technologies, and increasing demand for minimally invasive orthopedic procedures are some of the key factors driving the market growth. However, higher costs of orthopedic implants are still a major constraint for the growth of the orthopedic implants market. 

The orthopedic implants market refers to the segment of the medical device industry that develops, manufactures, and sells implants used to support or replace damaged bones, joints, or cartilage. These implants are crucial in treating orthopedic disorders caused by trauma and degenerative diseases (like arthritis). The market includes a variety of products such as joint reconstruction implants (hip, knee, shoulder), spinal implants, trauma fixation devices (plates, screws, rods), and ortho biologics (bone grafts and substitutes).

To request a free sample copy of this report, please visit below
https://meditechinsights.com/orthopedic-implants-market/request-sample/

Rising burden of musculoskeletal disorders and injuries increases demand for orthopedic implants

Musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and osteoporosis are becoming more common due to increasing aging populations and sedentary lifestyles. Similarly, rising participation in sports and physical activities has led to a higher incidence of injuries like ligament tears, fractures, and dislocations. According to the American Academy of Pediatrics and the National SAFE KIDS Campaign, over 3.5 million children aged 14 and under suffer injuries each year while playing sports or engaging in recreational activities. More than 775,000 children in the same age group are treated in emergency rooms for sports-related injuries annually. The rising number of road accidents is leading to more trauma cases requiring implant-based bone reconstruction. As a result, the need for orthopedic implants like plates, screws, rods, and joint replacements is skyrocketing to restore mobility, reduce pain, and improve patients’ quality of life.

Recent developments in the orthopedic implants market

  • In October 2024, Johnson & Johnson MedTech Launches VOLT Plating System which offers an expanded range of plate shapes, lengths, and screw lengths to accommodate different fracture reduction and fixation needs. The implants are designed to minimize prominence to reduce the risk of soft tissue irritation
  • In July 2024, Orthofix Medical Inc. announced the 510(k) clearance and first US implant of the Fitbone Transport and Lengthening System, designed to treat large bone defects in the femur and tibia due to trauma, infectious or malignant conditions, through a single surgery
  • In October 2023, DePuy Synthes received FDA Clearance for TriLEAP Lower Extremity Anatomic Plating System, a modular, procedure-specific plating solution for forefoot, midfoot, and hindfoot elective and trauma procedures

Integration of AR, and 3D printing in orthopedic procedures to supplement its growth

Augmented reality supports surgeons by improving visualization and navigation. Meanwhile, 3D printing enables the creation of patient-specific implants based on individual anatomical data, ensuring a better fit, improved functionality, and faster recovery. Together, these technologies are driving a shift toward personalized, minimally invasive procedures, significantly improving surgical outcomes and patient satisfaction. For instance, in February 2025, Maxx Orthopedics received FDA 510(k) clearance of 3D printed Porous Titanium Tibial Baseplate for Freedom Total Knee System, designed to support cementless fixation and expand implant options

Emergence of smart implants, digital templating, and advanced materials in orthopedic care

The adoption of smart implants embedded with biosensors is revolutionizing post-operative care by providing real-time data on load distribution, mobility, and implant performance. This allows for continuous monitoring and personalized treatment adjustments, enhancing patient recovery. Digital templating, which leverages advanced imaging and software to simulate implant placement before surgery, ensures better alignment, reduced operative time, and improved clinical outcomes. Additionally, the use of titanium alloys, known for their superior biocompatibility and strength, remains a key material trend in implant design. For instance, in February 2024, Tyber Medical LLC gained approval from Health Canada for its anatomical plating system. The system features a complete range of titanium and stainless-steel plates.

Competitive Landscape Analysis

The global orthopedic implants market is marked by the presence of established and emerging market players such as Arthrex, Inc.; CONMED Corporation; Globus Medical, Inc.; DePuy Synthes (Johnson & Johnson MedTech); Medtronic plc; Smith & Nephew plc; Stryker Corporation; Zimmer Biomet Holdings Inc.; B. Braun SE; Madison Ortho; Exactech, Inc.; Medacta International; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

 ðŸ”— Want deeper insights? Download the sample report here:
https://meditechinsights.com/orthopedic-implants-market/request-sample/

Global Orthopedic Implants Market Segmentation

This report by Medi-Tech Insights provides the size of the global orthopedic implants market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, material, and end-user

Market Size & Forecast (2023-2030), By Product, USD Million

  • Knee Implants
  • Hip Implants
  • Spinal Implants
  • Trauma Implants
  • Dental Implants
  • Others

Market Size & Forecast (2023-2030), By Material, USD Million

  • Metallic
  • Ceramic
  • Polymeric
  • Others

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgery Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 
info@meditechinsights.com 

Comments

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...